RESUMO
BACKGROUND: Hyperuricemia is a common adverse event frequently found in renal transplant recipients with mizoribine (MZ). Hyperuricemia itself will be a cause of renal dysfunction, and renal dysfunction also will be a cause of hyperuricemia simultaneously. This study investigates frequency of hyperuricemia and renal failure in renal transplant recipients treated with high-dose MZ. PATIENTS AND METHODS: From December 2007 to October 2015, there was a total of 32 living related renal transplant recipients treated with high-dose MZ. Of the 32 patients, 28 were treated with urate-lowering medications. RESULTS: One patient received allopurinol (AP) and 13 patients received benzbromarone (BB). For 6 of them, their urate-lowering medications were converted to febuxostat (FX) form AP or BB. In the remaining 14 patients, FX was administered from the beginning. In 2 cases of ABO-incompatible living related renal transplant recipients who were maintained with high-dose MZ and BB, severe hyperuricemia and acute renal failure occurred. One patient was a 48-year-old man, and his creatinine (Cr) level increased to 8.14 mg/dL and his serum uric acid (UA) was 24.6 mg/dL. Another patient was a 57-year-old man, and his Cr level increased to 3.59 mg/dL and his UA was 13.2 mg/dL. In both cases Cr and UA were improved, and no finding of acute rejection and drug toxicity was observed in graft biopsy specimens. BB was switched to FX and discontinuance or reduction of MZ was done. CONCLUSION: Combination of MZ and BB has the risk of acute renal dysfunction after renal transplantation. Latent renal dysfunction should be watched for in renal transplant recipients receiving high-dose MZ.
Assuntos
Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/etiologia , Hiperuricemia/epidemiologia , Hiperuricemia/etiologia , Transplante de Rim/efeitos adversos , Adulto , Alopurinol/uso terapêutico , Benzobromarona/efeitos adversos , Febuxostat/uso terapêutico , Humanos , Imunossupressores/efeitos adversos , Masculino , Pessoa de Meia-Idade , Ribonucleosídeos/efeitos adversos , Ribonucleosídeos/uso terapêutico , Transplantados , Ácido Úrico/sangue , Uricosúricos/efeitos adversosRESUMO
BACKGROUND: Stimulation of transient receptor potential ankyrin 1 (TRPA1), which abundantly expressed in enterochromaffin cells (ECC), has been reported to exert apparently contradictory results in in vitro contractility and in vivo gastrointestinal (GI) transit evaluations. The pharmaceutical-grade Japanese traditional medicine daikenchuto (TU-100) has been reported to be beneficial for postoperative ileus (POI) and accelerate GI transit in animals and humans. TU-100 was recently shown to increase intestinal blood flow via stimulation of TRPA1 in the epithelial cells of the small intestine (SI). METHODS: The effects of various TRPA1 agonists on motility were examined in a manipulation-induced murine POI model, in vitro culture of SI segments and an ECC model cell line, RIN-14B. KEY RESULTS: Orally administered TRPA1 agonists, aryl isothiocyanate (AITC) and cinnamaldehyde (CA), TU-100 ingredients, [6]-shogaol (6S) and γ-sanshool (GS), improved SI transit in a POI model. The effects of AITC, 6S and GS but not CA were abrogated in TRPA1-deficient mice. SI segments show periodic peristaltic motor activity whose periodicity disappeared in TRPA1-deficient mice. TU-100 augmented the motility. AITC, CA and 6S increased 5-HT release from isolated SI segments and the effects of all these compounds except for CA were lost in TRPA1-deficient mice. 6S and GS induced a release of 5-HT from RIN-14B cells in a dose- and TRPA1-dependent manner. CONCLUSIONS & INFERENCES: Intraluminal TRPA1 stimulation is a potential therapeutic strategy for GI motility disorders. Further investigation is required to determine whether 5-HT and/or ECC are involved in the effect of TRPA1 on motility.
Assuntos
Modelos Animais de Doenças , Trânsito Gastrointestinal/efeitos dos fármacos , Trânsito Gastrointestinal/fisiologia , Íleus/tratamento farmacológico , Canal de Cátion TRPA1/agonistas , Canal de Cátion TRPA1/fisiologia , Acroleína/análogos & derivados , Acroleína/farmacologia , Acroleína/uso terapêutico , Amidas/farmacologia , Amidas/uso terapêutico , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Íleus/fisiopatologia , Masculino , Camundongos , Camundongos da Linhagem 129 , Camundongos Endogâmicos C57BL , Naftoquinonas/farmacologia , Naftoquinonas/uso terapêutico , Técnicas de Cultura de ÓrgãosRESUMO
UNLABELLED: Serum sclerostin levels could be closely associated with serum phosphate and fibroblast growth factor-23 levels in hemodialysis patients with low intact parathyroid hormone (PTH) levels. Further study is required to indicate whether these close associations are present in patients with spontaneously low PTH levels without any vitamin D treatment. INTRODUCTION: Intact parathyroid hormone (iPTH) is involved in the interaction between sclerostin and phosphate/fibroblast growth factor-23 (FGF23) in animal models. However, their relationship in patients on hemodialysis (HD) is unclear. METHODS: Data of 102 HD patients were collected regarding clinical and laboratory parameters and mineral bone disorder medications. The patients were divided into subgroups according to the iPTH level (A, <70 pg/mL; B, 70-150 pg/mL; C, 150-300 pg/mL; and D, ≥ 300 pg/mL). RESULTS: The sclerostin level was significantly and positively correlated with phosphate and log of FGF23 levels in subgroups A, B, and combined A and B. Multiple linear regression analysis in the combined A and B subgroup revealed that male sex (t = 3.24, P = 0.01; 95% confidence interval [CI] 11.78 to 50.43) and phosphate level (t = 2.13, P = 0.04; 95% CI, 1.08 to 36.91) were independent factors for serum sclerostin level. The log of serum FGF23 level (t = 1.90, P = 0.06, 95% CI -1.85 to 63.50) appeared to be an important factor for serum sclerostin level. The frequency of patients using vitamin D treatment was not significantly different among subgroups A (93.1%), B (88.0%), C (85.2%), and D (90.5%). CONCLUSION: Serum sclerostin levels were associated with serum phosphate and FGF23 levels in patients with low iPTH levels. Further study is required to indicate whether these close associations are present in patients with spontaneously low iPTH levels without vitamin D treatment.
Assuntos
Proteínas Morfogenéticas Ósseas/sangue , Hormônio Paratireóideo/deficiência , Diálise Renal , Vitamina D/uso terapêutico , Proteínas Adaptadoras de Transdução de Sinal , Adulto , Idoso , Biomarcadores/sangue , Estudos de Casos e Controles , Suplementos Nutricionais , Feminino , Fator de Crescimento de Fibroblastos 23 , Fatores de Crescimento de Fibroblastos/sangue , Marcadores Genéticos , Humanos , Falência Renal Crônica/sangue , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Hormônio Paratireóideo/sangue , Fosfatos/sangue , Adulto JovemRESUMO
In this paper, we discuss a new method of controlling heating location in the proposed resonant cavity applicator. A dielectric bolus was used to non-invasively treat brain tumors. We have already confirmed that our heating system using resonant cavity is useful to non-invasively heat brain tumors. In order to heat tumors occurring at various locations, it is necessary to control the heating area with our heating system. First, we presented the proposed heating method and a phantom model to calculate temperature distributions. The results of temperature distributions were discussed. Second, a 3-D human head model constructed from 2-D MRI images was presented. The results of specific absorption rate distributions were discussed. From these results, it was found that the proposed heating method was useful to non-invasively treat brain tumors.
Assuntos
Neoplasias Encefálicas/terapia , Hipertermia Induzida/instrumentação , Hipertermia Induzida/métodos , Modelos Biológicos , Simulação por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Humanos , Imagens de Fantasmas , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Resultado do TratamentoRESUMO
A re-entrant resonant cavity applicator system for non-invasive brain tumor hyperthermia treatments was presented. We have already confirmed the effectiveness of the heating properties of this heating system with cylindrical agar phantoms and with computer simulations.
Assuntos
Neoplasias Encefálicas/terapia , Cabeça/anatomia & histologia , Hipertermia Induzida/métodos , Processamento de Imagem Assistida por Computador/métodos , Modelos Anatômicos , Simulação por Computador , Desenho Assistido por Computador , Olho/anatomia & histologia , Análise de Elementos Finitos , Humanos , Imageamento por Ressonância Magnética , Tomografia Computadorizada por Raios XRESUMO
We previously found that conophylline, an alkaloid isolated from the leaves of Ervatamia microphylla, induced beta-cell differentiation in rat pancreatic acinar carcinoma cells and in cultured fetal rat pancreatic tissue and that it also decreased the blood glucose level in streptozotocin-treated fetal rats. In the present research, we looked into the effect of conophylline on the differentiation of newborn pig pancreatic endocrine cells into insulin-secreting cells. Conophylline potentiated the differentiation of monolayer cells into insulin-producing cells in the presence of nicotinamide in 3 weeks. Next we prepared islet-like cell clusters (ICC). Cononophylline together with nicotinamide also increased the number of insulin-producing cells and the insulin content in ICC in 3-6 weeks. The ICC thus prepared were sensitive to the glucose concentration for the insulin secretion. Conophylline increased the mRNA expression of PDX-1, neurogenin3, neuroD/Beta2, and insulin in ICC. Thus, the vinca alkaloid conophylline potentiated beta-cell differentiation in porcine pancreatic endocrine-rich cells in cluster cultures. Pig pancreatic cells are practical candidate for use in transplantation therapy. Conophylline may thus be useful for the large-scale preparation of porcine insulin-producing cells for the regeneration therapy of type-1 diabetes mellitus.
Assuntos
Ilhotas Pancreáticas/efeitos dos fármacos , Alcaloides de Vinca/farmacologia , Animais , Animais Recém-Nascidos , Biomarcadores , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Regulação da Expressão Gênica/efeitos dos fármacos , Glucose/farmacologia , Insulina/metabolismo , Secreção de Insulina , Ilhotas Pancreáticas/metabolismo , Estrutura Molecular , Niacinamida/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sus scrofa , Suínos , Alcaloides de Vinca/químicaRESUMO
The evaluation of iron status in dialysis patients provides information essential to the planning of adequate recombinant human erythropoietin treatment. The cellular iron status of the patients can be determined from the recently available measurement of reticulocyte hemoglobin equivalent (RET-He). RET-He is measured on the basis of automated fluorescent flow cytometry which in the reticulocyte channel, using a polymethine dye, also measures the mean value of the forward light scatter intensity of mature red blood cells and reticulocytes. These values equate with reticulocyte hemoglobin content. In this study, to clarify the accuracy of RET-He in diagnosing iron deficiency in dialysis patients, we initially compared RET-He with such iron parameters as serum ferritin levels, transferrin saturation and content of reticulocyte hemoglobin (CHr) which has been established as indicators of functional iron deficiency. Secondly, we investigated the changes in RET-He during iron supplementation for iron-deficient patients to determine whether this marker is a prospective and reliable indicator of iron sufficiency. The participants in this study were 217 haemodialysis patients. Iron deficiency was defined as havsing a transferrin saturation (TSAT) < 20% or serum ferritin < 100 ng/ml. Conventional parameters of red blood cells and RET-He were measured by on a XE-2100 automated blood cell counter (Sysmex). CHr was measured on an ADVIA120 autoanalyser (Siemens). RET-He mean value was 32.4 pg and good correlation (r = 0.858) between RET-He and CHr is obtained in dialysis patients. Receiver operating characteristic curve analysis revealed, values of the area was 0.776 and at a cutoff value of 33.0 pg, a sensitivity of 74.3% and a specificity of 64.9%, were achieved. Iron supplements given to the patients with low TSAT or ferritin, RET-He responded within 2 weeks, and this seemed to be a potential advantage of using RET-He in the estimation of iron status. RET-He is a new parameter, equivalent value to CHr, and is easily measurable on the widely spread and popular blood cell counter and is a sensitive and specific marker of iron status in dialysis patients.
Assuntos
Anemia Ferropriva/diagnóstico , Hemoglobinas , Deficiências de Ferro , Ferro/sangue , Diálise Renal , Reticulócitos/química , Biomarcadores/química , Humanos , Curva ROC , Contagem de ReticulócitosRESUMO
This paper discusses the heating properties of a new type of hyperthermia system composed of a re-entrant type resonant cavity applicator for deep tumors of the abdominal region. In this method, a human body is placed in the gap of two inner electrodes and is non-invasively heated with electromagnetic fields stimulated in the cavity. Here, we calculated temperature distributions of a simple human abdominal phantom model that we constructed to examine the heating properties of the developed hyperthermia system. First, the proposed heating method and a simple abdominal model to calculate the temperature distribution are presented. Second, the computer simulation results of temperature distribution by 3-D FEM are presented. From these results, it was found that the proposed simple human abdominal phantom model composed of muscle, fat and lung was useful to test the heating properties of our heating method. Our heating method was also effective to non-invasively heat abdominal deep tumors.
Assuntos
Neoplasias Abdominais/terapia , Campos Eletromagnéticos , Hipertermia Induzida/métodos , Imageamento Tridimensional/métodos , Neoplasias/terapia , Algoritmos , Simulação por Computador , Desenho de Equipamento , Temperatura Alta , Humanos , Músculos/patologia , Imagens de Fantasmas , Temperatura , TransdutoresRESUMO
Since the human brain is protected by the skull, it is not easy to non-invasively heat deep brain tumors with electromagnetic energy for hyperthermia treatments. Generally, needle type applicators were used in clinical practice to heat brain tumors. To expand the heating area of needle type applicators, we have developed a new type of needle made of a shape memory alloy (SMA). In this paper, heating properties of the proposed SMA needle type applicator were discussed. Here, in order to apply the SMA needle type applicator clinically. First, we constructed an anatomical 3-D FEM model from MRI and X-ray CT images using 3D-CAD software. Second, we estimated electric and temperature distributions to confirm the SMA needle type applicator using the FEM soft were JMAG-Studio. From these results, it was confirmed that the proposed method can expand the heating area and control the heating of various sizes of brain tumors.
Assuntos
Neoplasias Encefálicas/terapia , Cabeça/fisiologia , Temperatura Alta , Hipertermia Induzida/métodos , Imagens de Fantasmas , Algoritmos , Ligas , Humanos , Processamento de Imagem Assistida por Computador , Imageamento Tridimensional , Imageamento por Ressonância Magnética/métodos , Radiação , Software , Temperatura , Tomografia Computadorizada por Raios X/métodosRESUMO
In this paper, we discuss the improvement of the speed of AIMS (Automatic Impedance Matching System) to automatically make impedance matching for a re-entrant resonant cavity applicator for non-invasive deep brain tumors hyperthermia treatments. We have already discussed the effectiveness of the heating method using the AIMS, with experiments of heating agar phantoms. However, the operating time of AIMS was about 30 minutes. To develop the ATT System (Automatic Totally Tuning System) including the automatic frequency tuning system, we must improve this problem. Because, when using the ATTS, the AIMS is used repeatedly to find the resonant frequency. In order to improve the speed of impedance matching, we developed the new automatic impedance matching system program (AIMS2). In AIMS, the stepping motors were connected to the impedance matching unit's dials. These dials were turned to reduce the reflected power. AIMS consists of two phases: all range searching and detailed searching. We focused on the three factors affecting the operating speed and improved them. The first factor is the interval put between the turning of the motors and AD converter. The second factor is how the steps of the motor when operating all range searching. The third factor is the starting position of the motor when detail searching. We developed the simple ATT System (ATT-beta) based on the AIMS2. To evaluate the developed AIMS2 and ATT- beta, experiments with an agar phantom were performed. From these results, we found that the operating time of the AIMS2 is about 4 minutes, which was approximately 12% of AIMS. From ATT-beta results, it was shown that it is possible to tune frequency and automatically match impedance with the program based on the AIMS2.
Assuntos
Hipertermia Induzida/métodos , Ágar/química , Automação , Neoplasias Encefálicas/terapia , Simulação por Computador , Computadores , Impedância Elétrica , Desenho de Equipamento , Humanos , Imagens de Fantasmas , Processamento de Sinais Assistido por Computador/instrumentação , Software , Temperatura , Fatores de Tempo , TransdutoresRESUMO
The patient was a 17-year-old man, who developed Japanese encephalitis in the autumn of 1990 in Japan. He was admitted to our hospital 4 days after onset because of consciousness disturbance. On admission, neurological examination demonstrated left hemiparesis, neck stiffness, and Kernig's sign. He developed generalized tonico-clonic seizure, and required a respirator on the next day of admission. Brain CT 10 days after onset demonstrated hypodensities in the right hippocampus, and the CT obtained 39 days after onset showed whole brain atrophy and hypodensities in the anterior portion of the bilateral thalamus. He died 40 days after onset. Postmortem examination demonstrated perivascular and parenchymal infiltration of lymphocytes and macrophages, proliferation of microglia and astrocytes, and necrosis in the gray matter of the brain. Involvement of the hippocampus and thalamus on CT seemed to reflect the severe lesions characterized by cellular infiltration and necrosis. We discussed for the first time the correlation of CT and neuropathological findings in a patient with Japanese encephalitis.
Assuntos
Encéfalo/diagnóstico por imagem , Encefalite Japonesa/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Adolescente , Encéfalo/patologia , Encefalite Japonesa/patologia , Hipocampo/diagnóstico por imagem , Hipocampo/patologia , Humanos , Masculino , Necrose/diagnóstico por imagem , Necrose/patologia , Tálamo/diagnóstico por imagem , Tálamo/patologiaRESUMO
OBJECTIVES: The cause of hypocretin cell loss in human narcolepsy-cataplexy is unknown but has been suggested to be neurodegenerative in nature. To test this hypothesis, we evaluated the remaining hypocretin cells in human narcolepsy brains for the presence of aggregated protein inclusions, gliosis, and inflammation. METHODS: Brains were examined by routine histologic methods for potential comorbid neurodegenerative diseases and through immunohistochemical screening for protein inclusions in the hypothalamus. Hypothalamic sections of 4 subjects with narcolepsy and 5 nonneurologic controls were examined immunohistochemically with antibodies against ubiquitin (a marker of aggregated protein), allograft inflammatory factor 1 (AIF1, a microglial activation marker), glial fibrillary acidic protein (GFAP, a reactive astrocytic marker), and hypocretin. Hypothalami of subjects with narcolepsy were additionally examined for the presence of known components of protein aggregates (tau, alpha-synuclein, amyloid beta, and TDP-43). RESULTS: Hypocretin cells were markedly decreased in all 4 subjects with narcolepsy. Ubiquitinated inclusions were not observed in the total of 96 remaining hypocretin cells in these subjects. Further, we noted that even in patients with dementia neuropathology, the lateral hypothalamic hypocretin area was spared from ubiquitinated inclusions. AIF1 and GFAP staining in the perifornical area was unremarkable. CONCLUSIONS: Our findings suggest that hypocretin cell loss does not involve ubiquitinated inclusions, the hallmark of most neurodegenerative diseases. The lack of increased markers of inflammation also argues against a progressive and continuous neurodegenerative process.
Assuntos
Hipotálamo/patologia , Corpos de Inclusão/patologia , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Narcolepsia/patologia , Doenças Neurodegenerativas/patologia , Neurônios/patologia , Neuropeptídeos/metabolismo , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/análise , Biomarcadores/metabolismo , Proteínas de Ligação ao Cálcio , Proteínas de Ligação a DNA/metabolismo , Encefalite/patologia , Feminino , Proteína Glial Fibrilar Ácida/metabolismo , Gliose/patologia , Humanos , Hipotálamo/metabolismo , Hipotálamo/fisiopatologia , Corpos de Inclusão/metabolismo , Masculino , Proteínas dos Microfilamentos , Narcolepsia/fisiopatologia , Doenças Neurodegenerativas/fisiopatologia , Neurônios/metabolismo , Orexinas , Ubiquitina/análise , Ubiquitina/metabolismo , Ubiquitinação/fisiologiaRESUMO
In this paper, we have proposed a new heating method in which high frequency electric fields in a re-entrant type resonant cavity are used for the heating of deeply seated tumors. In this method, a human head is placed between the gap of the inner re-entrant cylinders, and is heated with electromagnetic fields stimulated in the cavity without contact between the surface of the human head and the applicator. Here, we proposed a new method to control the heating area. In this method, the resonant frequency inside the cavity was changed, then we use the TM010-like mode and the TM012-like mode from various types of the resonant frequency. First, the computer simulation results of electric and magnetic field patterns are presented. Second, a comparison of the heating properties of TM010-like mode and TM012-like mode are discussed. The heating area of the center of agar phantom is more concentrated by using TM012-like mode than that of using TM010-like mode. From these results, it is confirmed that the proposed method can be controlled to heat the various sizes of deep tumors.
Assuntos
Neoplasias Encefálicas/fisiopatologia , Neoplasias Encefálicas/terapia , Hipertermia Induzida/instrumentação , Modelos Biológicos , Terapia por Radiofrequência , Terapia Assistida por Computador/métodos , Transdutores , Simulação por Computador , Desenho Assistido por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Análise de Elementos Finitos , Temperatura Alta , Humanos , Hipertermia Induzida/métodos , Terapia Assistida por Computador/instrumentaçãoRESUMO
This paper discusses a new method to control the heating area of a re-entrant resonant cavity applicator for brain tumor hyperthermia treatment non-invasively. We have already discussed about the effectiveness of a developed system with experiments of heating an agar phantom and computer simulations. Here, in order to heat a deep brain tumor, we propose the heating method of using several electromagnetic heating modes which are transverse magnetic (TM) modes. In this method, TM010-like and TM012-like modes obtained by selecting resonant frequencies can be used to heat the deep brain tumors. To control the heating area of the modes the agar phantom is used in the heating experiments by the developed system. From these results, we found that the heating area of the agar phantom by using TM012-like mode is about 50% of the heating area of TM010-like mode. It is found that the proposed heating system can be applicable to the hyperthermia treatment of brain tumors corresponding to the size and the position where it occurred.
Assuntos
Neoplasias Encefálicas/terapia , Hipertermia Induzida/instrumentação , Hipertermia Induzida/métodos , Modelos Biológicos , Simulação por Computador , Desenho Assistido por Computador , Campos Eletromagnéticos , Desenho de Equipamento , Análise de Falha de Equipamento , Temperatura Alta , Humanos , Terapia Assistida por Computador/métodosRESUMO
This paper discusses the heating properties of a new type hyperthermia system composed of a re-entrant type resonant cavity applicator for a deep tumor of the abdominal region. In this heating method, a human body is placed between the two inner electrodes, and is heated with electromagnetic fields stimulated in the cavity without contact between the surface of the human body and the applicator. First, the experimental heating results of an agar-muscle equivalent phantom were presented. Second, we performed an experiment with a lard-agar phantom. The center region of the agar phantom could be heated selectively without generating hot spots in the lard layers. From these results, it was found that our newly developed heating method is useful for a deep-seated tumor hyperthermia treatment.
Assuntos
Hipertermia Induzida , Neoplasias/terapia , Ágar , Humanos , Processamento de Imagem Assistida por Computador , Imagens de Fantasmas , TermodinâmicaRESUMO
A re-entrant type resonant cavity applicator for brain tumor hyperthermia treatment is presented. In this method, a human brain is placed between the gap of the inner re-entrant cylinders without contact. This cavity has a window for insertion of the human head. Here, first, to design and construct a resonant cavity applicator, the results of the temperature distribution inside an agar phantom and electromagnetic field leaked from the attached window to the environment by the computer simulation were presented. Second, The developed resonant cavity and inner electrode, which were made of an aluminum alloy, were presented. Third, the experimental heating result of the agar phantom was presented. In the experiment, the center region of the agar phantom is heated to 42 degrees C. The leaked electric field strength at the position of 10 cm away from the center of the window was less than that of 10% of the center of the agar phantom. It was found that the developed resonant cavity applicator was applicable to both deep and regional brain hyperthermia treatment.
Assuntos
Neoplasias Encefálicas/terapia , Hipertermia Induzida/instrumentação , Eletrodos , Desenho de Equipamento , Humanos , Hipertermia Induzida/métodos , Imagens de Fantasmas , TemperaturaRESUMO
A re-entrant type resonant cavity applicator for brain tumor hyperthermia treatment is presented. In this method, a human head is placed between the gap of the inner re-entrant cylinders, and is heated with electromagnetic fields stimulated in the cavity without contact between the surface of the human head and the applicator. First, the comparison of the computer simulation and experimental results were presented. The estimated temperature agrees with the measured temperature with an error of 10% or better. Second, a method to control the heating pattern was presented. In the method, a human head was moved towards the electrode. The controllable range of heating pattern was about 70% of the distance from the center of the agar phantom in the direction of depth.
Assuntos
Neoplasias Encefálicas/terapia , Calefação , Hipertermia Induzida/instrumentação , Ágar , Temperatura Corporal , Simulação por Computador , Eletrodos , Desenho de Equipamento , Cabeça , Temperatura Alta , Humanos , Hipertermia Induzida/métodos , Imagens de Fantasmas , TemperaturaRESUMO
BACKGROUND: The evaluation of iron status in dialysis patients provides information essential to the planning of adequate recombinant human erythropoietin (rHuEPO) treatment. Iron status of the patients can be determined from the recently available measurement of content of reticulocyte hemoglobin (CHr). METHODS: In this study, to clarify the accuracy of CHr in diagnosing iron deficiency in hemodialysis (HD) patients, we initially compared CHr with such conventional iron parameters as serum ferritin levels, transferrin saturation and serum soluble transferrin receptor levels. Secondly, we investigated the changes in CHr during iron supplementation for iron-deficient patients to determine whether this marker is a prospective and reliable indicator of iron sufficiency. The participants in this study were 149 hemodialysis (HD) patients and 53 age-matched healthy subjects. Iron deficiency was defined as having a TSAT of less than 20% and serum ferritin of less than 100 ng/ml. Conventional parameters of red blood cells and CHr were measured by an ADVIA120 autoanalyzer. RESULTS: Mean CHr was 32.3 +/- 2.2 pg in the patients undergoing hemodialysis treatment. CHr significantly correlated with iron parameters in the dialysis patients. Logistic regression analysis was performed to determine the relationship between CHr and each outcome measure, and CHr was the significant multivariate predictor of iron deficiency. Iron supplements given to the patients with low CHr and hematocrit (Hct) significantly increased Hct, resulting in a decrease in the weekly dosage of rHuEPO. CONCLUSIONS: CHr, measured simultaneously with Hct, is a sensitive and specific marker of iron status in dialysis patients.
Assuntos
Anemia Ferropriva/sangue , Ferritinas/sangue , Hemoglobinas/análise , Falência Renal Crônica/terapia , Diálise Renal/efeitos adversos , Transferrina/análise , Adulto , Anemia Ferropriva/etiologia , Anemia Ferropriva/terapia , Índices de Eritrócitos , Eritropoetina/uso terapêutico , Feminino , Humanos , Falência Renal Crônica/sangue , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Proteínas Recombinantes , Reticulócitos/químicaRESUMO
Carmofur (1-hexylcarbamyl-5-fluorouracil), a derivative of 5-fluorouracil (5-FU), has been widely used in Japan as a postoperative adjuvant chemotherapy agent for colorectal and breast cancer. Periventricular hyperintensity on T2-weighted MR images in carmofur-induced leukoencephalopathy confront the physician with a broad range of differential diagnoses. We describe two cases of carmofur-induced leukoencephalopathy in which diffusion-weighted MR imaging revealed periventricular hyperintensity. We compared their findings with those of age-related periventricular hyperintensity in five patients and found discrepancies in signal intensity of periventricular areas. Our results suggest that diffusion-weighted MR imaging may be useful to differentiate carmofur-induced leukoencephalopathy from age-related periventricular hyperintensity.
Assuntos
Antineoplásicos/efeitos adversos , Encefalopatias/induzido quimicamente , Encefalomalacia/induzido quimicamente , Fluoruracila/análogos & derivados , Fluoruracila/efeitos adversos , Aumento da Imagem , Imageamento por Ressonância Magnética , Adulto , Antineoplásicos/administração & dosagem , Encéfalo/patologia , Encefalopatias/diagnóstico , Neoplasias da Mama/tratamento farmacológico , Carcinoma Ductal de Mama , Quimioterapia Adjuvante , Difusão , Encefalomalacia/diagnóstico , Feminino , Fluoruracila/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias do Colo Sigmoide/tratamento farmacológicoRESUMO
CsOH- or Ag(2)O-mediated cycloalkylation of (alkylidene)bisperoxides 3 and 1,n-dihaloalkanes (n = 3-8) provided the corresponding medium-sized 1,2,4,5-tetraoxacycloalkanes 4-8 in moderate yields. Subsequent evaluation of the antimalarial activity of the cyclic peroxides 4-8 in vitro and in vivo revealed that 1,2,6,7-tetraoxaspiro[7.11]nonadecane 4a has considerable potential as a new, inexpensive, and potent antimalarial drug.